221 search results
- Current search:
- Developmental, Psychosocial and Learning Problems
- Reset
Primary tabs
- Cochrane Evidence (active tab)
- Resources
- Handbooks & Manuals
- Training & Workshops
- News
- All Cochrane sites
-
Cochrane EvidencePublished 4 Jul 2017
Splinting for the non-operative management of developmental dysplasia of the hip (DDH) in children under six months of age
Protocol: To determine the role of splinting and the optimal treatment strategy for the non-operative management of DDH in children under six months of age. To identify if there are particular subgroups of patients for whom the optimal management strategy may differ. -
NewCochrane EvidencePublished 11 Jun 2017
Exercise interventions for improving activity, participation and quality of life in people with cerebral palsy
Review question Does exercise improve activity, participation in life situations and quality of life in people with cerebral palsy (CP)? Background Cerebral palsy (CP) is caused by an injury to an infant's brain that interrupts normal development. People with CP have reduced muscle strength and aerobic fitness, which may impact their ability to ... -
Cochrane EvidencePublished 16 May 2017
Family therapy for autism spectrum disorders
Review question What is the evidence that family therapy can help to improve communication, strengthen relationships, and enhance coping, mental health and well-being for people who have autism spectrum disorders (ASDs) or their family members, or both? Background People with ASD often experience difficulty with knowing how to communicate with others, ... -
TitlePublished 7 May 2017
Mechanically-assisted walking training for children with cerebral palsy
Developmental, Psychosocial and Learning Problems Group Hsiu-Ching Chiu Title Friday, May 5, 2017 ... -
Cochrane EvidencePublished 2 May 2017
Provision of folic acid for reducing arsenic toxicity in arsenic-exposed children and adults
Protocol: To assess the effects of the provision of folic acid (through folic acid fortified foods or supplements), alone or in combination with other nutrients, on arsenic toxicity and arsenic-related health outcomes (i.e. neurocognitive function, skin lesions, congenital disorders and cancer) in arsenic-exposed populations. -
Cochrane EvidencePublished 29 Mar 2017
Lipid-based nutrient supplements for pregnant women and their impact on pregnancy, birth, and infant developmental outcomes in stable and emergency settings
Protocol: To review the effects of lipid-based nutrient supplements (LNS) when given to women during pregnancy, and their impact on maternal, birth and infant outcomes. To explore the most appropriate composition, frequency and duration of LNS. -
Cochrane EvidencePublished 29 Mar 2017
Provision of preventive lipid-based nutrient supplements given with complementary foods to infants and young children 6 to 23 months of age for health, nutrition, and developmental outcomes
Protocol: To assess the effects and safety of preventive lipid-based nutrient supplements (LNS) given with complementary foods on health, nutrition and developmental outcomes of non-hospitalised infants and children 6 to 23 months of age, and whether or not they are more effective than other foods. This review will not assess the effects of ... -
Cochrane EvidencePublished 23 Mar 2017
Dietary interventions for recurrent abdominal pain in children
Review question We reviewed the evidence on the effects of dietary interventions on pain in children aged between five and 18 years with recurrent abdominal pain (RAP). Background Recurrent abdominal pain, or RAP, is a term used for unexplained episodes of stomachache or abdominal pain in children. Recurrent abdominal pain is a common condition, ... -
Cochrane EvidencePublished 10 Mar 2017
Vitamin A supplementation for preventing disease and death in children aged six months to five years
Background Vitamin A deficiency (VAD) is a major public health problem in low- and middle-income countries, affecting 190 million children under five years of age. VAD predisposes children to increased risk of a range of problems, including respiratory diseases, diarrhoea, measles, and vision problems, and it can lead to death. Previous studies show ... -
Cochrane EvidencePublished 6 Mar 2017
Drug treatment of recurrent abdominal pain in children
Review question Do medications improve the pain or other symptoms experienced by children with recurrent abdominal pain (RAP)? Background Recurrent abdominal pain in childhood is a term used to describe unexplained episodes of tummy pain for which no cause can be found. The pain is often accompanied by other symptoms, such as diarrhoea or facial ...
